BIIO — Bionovate Technologies Balance Sheet
0.000.00%
FinancialsHighly SpeculativeMicro Cap
- $0.00m
- $0.19m
Annual balance sheet for Bionovate Technologies, fiscal year end - June 30th, USD millions except per share, conversion factor applied.
2017 June 30th | 2018 June 30th | 2019 June 30th | 2020 June 30th | 2021 June 30th | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 0 | 0 | 0 | 0 | 0 |
| Total Current Assets | 0 | 0 | 0 | 0 | 0 |
| Total Assets | 0 | 0 | 0 | 0 | 0 |
| Accounts Payable | |||||
| Payable / Accrued | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 0.229 | 0.31 | 0.332 | 0.397 | 0.503 |
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Liabilities | 0.229 | 0.31 | 0.332 | 0.397 | 0.503 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | -0.229 | -0.31 | -0.332 | -0.397 | -0.503 |
| Total Liabilities & Shareholders' Equity | 0 | 0 | 0 | 0 | 0 |
| Total Common Shares Outstanding |